from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1747/-

LFCtreatmentdescriptionclass of inhibitor

-0.579

Amikacinug/mL Amikacintranslation

-2.013

Cap5-10ug/mL Capreomycintranslation

-2.586

Rox10-50 ug/mL Roxithromycintranslation

-0.364

SM2-5 ug/mL Streptomycintranslation

-3.996

Tet5-10 ug/mL Tetracyclinetranslation

0.669

Rif0.2-5ug/mL Rifampicintranscription

0.525

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.535

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.815

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.356

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.071

Clofazimine10-13 ug/mL Clofaziminerespiration

0.491

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.335

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.775

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.909

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.347

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.067

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.449

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.613

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.888

KCN5-20 ug/mL Potassium cyaniderespiration

-0.097

NaN30.2-2 mM Sodium aziderespiration

-0.694

Nigericin50 uM Nigericinrespiration

0.010

TRC10-150 ug/mL Triclosanrespiration

0.176

TRZ10-25 ug/mL Thioridazinerespiration

-0.571

Valinomycin0.5-10 uM Valinomycinrespiration

0.241

ZnSO42 mM ZnSO4respiration

-0.176

menadione6-10 ug/mL Menadionerespiration

0.111

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.309

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.167

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.088

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.446

NRP_1Non-replicating persistence stage 1dosRassociated

-0.171

Amp0.2mg/mL AmpicillincellWall

0.094

Cephalexin20-100 ug/mL CephalexincellWall

0.429

Cerulenin0.32-5 ug/mL CerulenincellWall

0.137

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.054

EMB10-20 ug/mL EthambutolcellWall

0.423

Eta12-40 ug/mL EthionamidecellWall

0.487

INH0.2-0.4 ug/mL IsoniazidcellWall

0.252

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.648

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.547

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.572

BZA0.12 mg/mL BenzamidearomaticAmides

-0.135

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.014

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.592

H2O24 mM hydrogen peroxideDNAdamaging

0.200

Levo10 ug/mL LevofloxacinDNAdamaging

-0.070

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.301

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.102

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.023

UVUV-irradiationDNAdamaging

-0.046

ARP41-4 ug/mL Antitubercular compound ARP4?

0.195

Antimycin12.5-50 ug/mL Antimycin A?

-0.074

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.271

PA_110-50 ug/mL Antitubercular compound PA-1?

0.288

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.213

PA8240.2-2 ug/mL PA-824?

-0.291

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.866

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.003

Verapamil50 uM Verapamil?

-0.256

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.402

methoxatin10-20 ug/mL Methoxatin?